These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 26282175)

  • 1. Ligand-Independent EGFR Signaling.
    Guo G; Gong K; Wohlfeld B; Hatanpaa KJ; Zhao D; Habib AA
    Cancer Res; 2015 Sep; 75(17):3436-41. PubMed ID: 26282175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constitutive and ligand-induced EGFR signalling triggers distinct and mutually exclusive downstream signalling networks.
    Chakraborty S; Li L; Puliyappadamba VT; Guo G; Hatanpaa KJ; Mickey B; Souza RF; Vo P; Herz J; Chen MR; Boothman DA; Pandita TK; Wang DH; Sen GC; Habib AA
    Nat Commun; 2014 Dec; 5():5811. PubMed ID: 25503978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of EGFR-Met Interactions in the Pathogenesis of Glioblastoma and Resistance to Treatment.
    Guo G; Narayan RN; Horton L; Patel TR; Habib AA
    Curr Cancer Drug Targets; 2017; 17(3):297-302. PubMed ID: 28004613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of STAT3, MAPK, and AKT in malignant astrocytic gliomas: correlation with EGFR status, tumor grade, and survival.
    Mizoguchi M; Betensky RA; Batchelor TT; Bernay DC; Louis DN; Nutt CL
    J Neuropathol Exp Neurol; 2006 Dec; 65(12):1181-8. PubMed ID: 17146292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Constitutive EGFR Signaling Regulating IRF3 Transcriptional Activity in Cancer Cells.
    Guo G; Gong K; Habib AA
    Methods Mol Biol; 2017; 1652():183-189. PubMed ID: 28791644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic modifiers of EGFR dependence in non-small cell lung cancer.
    Sharifnia T; Rusu V; Piccioni F; Bagul M; Imielinski M; Cherniack AD; Pedamallu CS; Wong B; Wilson FH; Garraway LA; Altshuler D; Golub TR; Root DE; Subramanian A; Meyerson M
    Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18661-6. PubMed ID: 25512530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential gene expression analysis reveals generation of an autocrine loop by a mutant epidermal growth factor receptor in glioma cells.
    Ramnarain DB; Park S; Lee DY; Hatanpaa KJ; Scoggin SO; Otu H; Libermann TA; Raisanen JM; Ashfaq R; Wong ET; Wu J; Elliott R; Habib AA
    Cancer Res; 2006 Jan; 66(2):867-74. PubMed ID: 16424019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An EGFR wild type-EGFRvIII-HB-EGF feed-forward loop regulates the activation of EGFRvIII.
    Li L; Chakraborty S; Yang CR; Hatanpaa KJ; Cipher DJ; Puliyappadamba VT; Rehman A; Jiwani AJ; Mickey B; Madden C; Raisanen J; Burma S; Saha D; Wang Z; Pingle SC; Kesari S; Boothman DA; Habib AA
    Oncogene; 2014 Aug; 33(33):4253-64. PubMed ID: 24077285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paradigm of kinase-driven pathway downstream of epidermal growth factor receptor/Akt in human lung carcinomas.
    Dobashi Y; Suzuki S; Kimura M; Matsubara H; Tsubochi H; Imoto I; Ooi A
    Hum Pathol; 2011 Feb; 42(2):214-26. PubMed ID: 21040950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGFRvIII-mediated radioresistance through a strong cytoprotective response.
    Lammering G; Hewit TH; Valerie K; Contessa JN; Amorino GP; Dent P; Schmidt-Ullrich RK
    Oncogene; 2003 Aug; 22(36):5545-53. PubMed ID: 12944901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme.
    Shinojima N; Tada K; Shiraishi S; Kamiryo T; Kochi M; Nakamura H; Makino K; Saya H; Hirano H; Kuratsu J; Oka K; Ishimaru Y; Ushio Y
    Cancer Res; 2003 Oct; 63(20):6962-70. PubMed ID: 14583498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous exposure of non-small cell lung cancer cells with wild-type EGFR to an inhibitor of EGFR tyrosine kinase induces chemoresistance by activating STAT3.
    Tang J; Guo F; Du Y; Liu X; Qin Q; Liu X; Yin T; Jiang L; Wang Y
    Int J Oncol; 2015 May; 46(5):2083-95. PubMed ID: 25695284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrin-releasing peptide activates Akt through the epidermal growth factor receptor pathway and abrogates the effect of gefitinib.
    Liu X; Carlisle DL; Swick MC; Gaither-Davis A; Grandis JR; Siegfried JM
    Exp Cell Res; 2007 Apr; 313(7):1361-72. PubMed ID: 17349623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous activation and signaling by overexpressed epidermal growth factor receptors in glioblastoma cells.
    Thomas CY; Chouinard M; Cox M; Parsons S; Stallings-Mann M; Garcia R; Jove R; Wharen R
    Int J Cancer; 2003 Mar; 104(1):19-27. PubMed ID: 12532415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers.
    Yamadori T; Ishii Y; Homma S; Morishima Y; Kurishima K; Itoh K; Yamamoto M; Minami Y; Noguchi M; Hizawa N
    Oncogene; 2012 Nov; 31(45):4768-77. PubMed ID: 22249257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EGFR inhibition evokes innate drug resistance in lung cancer cells by preventing Akt activity and thus inactivating Ets-1 function.
    Phuchareon J; McCormick F; Eisele DW; Tetsu O
    Proc Natl Acad Sci U S A; 2015 Jul; 112(29):E3855-63. PubMed ID: 26150526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gefitinib (IRESSA) sensitive lung cancer cell lines show phosphorylation of Akt without ligand stimulation.
    Noro R; Gemma A; Kosaihira S; Kokubo Y; Chen M; Seike M; Kataoka K; Matsuda K; Okano T; Minegishi Y; Yoshimura A; Kudoh S
    BMC Cancer; 2006 Dec; 6():277. PubMed ID: 17150102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of PD-L1 Expression by the EML4-ALK Oncoprotein and Downstream Signaling Pathways in Non-Small Cell Lung Cancer.
    Ota K; Azuma K; Kawahara A; Hattori S; Iwama E; Tanizaki J; Harada T; Matsumoto K; Takayama K; Takamori S; Kage M; Hoshino T; Nakanishi Y; Okamoto I
    Clin Cancer Res; 2015 Sep; 21(17):4014-21. PubMed ID: 26019170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of epidermal growth factor receptor induces sequestration of extracellular signal-related kinases and selective attenuation of specific epidermal growth factor-mediated signal transduction pathways.
    Habib AA; Chun SJ; Neel BG; Vartanian T
    Mol Cancer Res; 2003 Jan; 1(3):219-33. PubMed ID: 12556561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD9 modulates proliferation of human glioblastoma cells via epidermal growth factor receptor signaling.
    Wang GP; Han XF
    Mol Med Rep; 2015 Jul; 12(1):1381-6. PubMed ID: 25760022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.